Gujarat Themis Biosyn Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 388.59 million compared to INR 281.65 million a year ago. Revenue was INR 398.63 million compared to INR 299.71 million a year ago. Net income was INR 130.13 million compared to INR 98.07 million a year ago. Basic earnings per share from continuing operations was INR 1.79 compared to INR 1.35 a year ago. Diluted earnings per share from continuing operations was INR 1.79 compared to INR 1.35 a year ago.
For the nine months, sales was INR 1,281 million compared to INR 1,208 million a year ago. Revenue was INR 1,311.8 million compared to INR 1,254.26 million a year ago. Net income was INR 432.78 million compared to INR 462.77 million a year ago. Basic earnings per share from continuing operations was INR 5.96 compared to INR 6.37 a year ago. Diluted earnings per share from continuing operations was INR 5.96 compared to INR 6.37 a year ago.